How is Carcinogenicity Assessed in Nanotechnology?
Assessing the carcinogenicity of nanomaterials involves a combination of in vitro (cell-based) and in vivo (animal-based) studies, as well as computational modeling. Key tests include:
Genotoxicity assays: These tests evaluate the potential of a substance to damage genetic material. Animal studies: Rodent models are often used to study the long-term effects of exposure to nanomaterials. Computational models: These models can predict the interactions between nanomaterials and biological systems based on their physicochemical properties.
